Indication

Immunologic Paralysis

1 clinical trial

1 product

Clinical trial

Investigating the Immunomodulatory Effects of Esmolol in Sepsis Management and Its Impact on Patient Outcomes

Status: Completed, Estimated PCD: 2023-12-31

Product